PRTAProthena Corporation plc

$502M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$507,000-59.2% YoY

Gross Profit

$507,000100.0% margin

Operating Income

-$29M-5768.0% margin

Net Income

-$30M-5852.1% margin

EPS (Diluted)

$-1.68

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$4M

Total Liabilities

$10M

Stockholders' Equity

-$6M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$507,000	$1M	-59.2%
Gross Profit	$507,000	$1M	-59.2%
Operating Income	-$29M	-$12M	-140.5%
Net Income	-$30M	-$12M	-137.7%

PRTA FY 2011 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena